Impedimed (Australia) Price History
IPD Stock | 0.05 0 1.92% |
Below is the normalized historical share price chart for Impedimed extending back to October 24, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Impedimed stands at 0.05, as last reported on the 27th of November, with the highest price reaching 0.05 and the lowest price hitting 0.05 during the day.
If you're considering investing in Impedimed Stock, it is important to understand the factors that can impact its price. Currently, Impedimed is out of control. Impedimed holds Efficiency (Sharpe) Ratio of 0.035, which attests that the entity had a 0.035% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Impedimed, which you can use to evaluate the volatility of the firm. Please check out Impedimed's Risk Adjusted Performance of 0.0154, market risk adjusted performance of 0.0536, and Downside Deviation of 4.23 to validate if the risk estimate we provide is consistent with the expected return of 0.16%.
At this time, Impedimed's Common Stock Shares Outstanding is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 12 M in 2024, whereas Common Stock is likely to drop slightly above 185.5 M in 2024. . Impedimed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of October 2007 | 200 Day MA 0.0705 | 50 Day MA 0.0568 | Beta 2.874 |
Impedimed |
Sharpe Ratio = 0.035
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | IPD | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
4.56 actual daily | 40 60% of assets are more volatile |
Expected Return
0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Impedimed is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Impedimed by adding it to a well-diversified portfolio.
Price Book 2.5827 | Enterprise Value Ebitda (9.34) | Price Sales 10.0011 | Shares Float 1.8 B | Wall Street Target Price 0.1457 |
Impedimed Stock Price History Chart
There are several ways to analyze Impedimed Stock price data. The simplest method is using a basic Impedimed candlestick price chart, which shows Impedimed price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 18, 2024 | 0.067 |
Lowest Price | September 10, 2024 | 0.044 |
Impedimed November 27, 2024 Stock Price Synopsis
Various analyses of Impedimed's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Impedimed Stock. It can be used to describe the percentage change in the price of Impedimed from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Impedimed Stock.Impedimed Accumulation Distribution | 71,848 | |
Impedimed Price Daily Balance Of Power | (0.25) | |
Impedimed Price Rate Of Daily Change | 0.98 |
Impedimed November 27, 2024 Stock Price Analysis
Impedimed Stock Price History Data
The price series of Impedimed for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 0.02 with a coefficient of variation of 9.19. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.05. The median price for the last 90 days is 0.06. The company completed 368:355 stock split on 3rd of April 2020.Open | High | Low | Close | Volume | ||
11/27/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 934,030 | |
11/26/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 1,467,505 | |
11/25/2024 | 0.06 | 0.06 | 0.05 | 0.05 | 1,115,272 | |
11/22/2024 | 0.05 | 0.06 | 0.05 | 0.06 | 2,263,828 | |
11/21/2024 | 0.05 | 0.06 | 0.05 | 0.05 | 2,011,259 | |
11/20/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 1,180,129 | |
11/19/2024 | 0.05 | 0.06 | 0.05 | 0.05 | 837,482 | |
11/18/2024 | 0.05 | 0.06 | 0.05 | 0.05 | 2,291,840 | |
11/15/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 1,292,107 | |
11/14/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 120,151 | |
11/13/2024 | 0.06 | 0.06 | 0.05 | 0.05 | 105,998 | |
11/12/2024 | 0.06 | 0.06 | 0.05 | 0.06 | 805,016 | |
11/11/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 1,124,281 | |
11/08/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 1,141,606 | |
11/07/2024 | 0.05 | 0.06 | 0.05 | 0.06 | 623,923 | |
11/06/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 697,048 | |
11/05/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 218,310 | |
11/04/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 326,440 | |
11/01/2024 | 0.05 | 0.06 | 0.05 | 0.06 | 587,107 | |
10/31/2024 | 0.06 | 0.06 | 0.05 | 0.06 | 405,182 | |
10/30/2024 | 0.06 | 0.06 | 0.05 | 0.05 | 1,079,304 | |
10/29/2024 | 0.06 | 0.06 | 0.05 | 0.06 | 2,047,848 | |
10/28/2024 | 0.06 | 0.06 | 0.05 | 0.06 | 1,413,571 | |
10/25/2024 | 0.06 | 0.06 | 0.05 | 0.06 | 795,978 | |
10/24/2024 | 0.06 | 0.06 | 0.05 | 0.06 | 1,790,183 | |
10/23/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 1,487,637 | |
10/22/2024 | 0.06 | 0.07 | 0.06 | 0.06 | 4,900,704 | |
10/21/2024 | 0.07 | 0.07 | 0.06 | 0.06 | 1,635,327 | |
10/18/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 941,019 | |
10/17/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 426,392 | |
10/16/2024 | 0.06 | 0.07 | 0.06 | 0.07 | 1,782,321 | |
10/15/2024 | 0.07 | 0.07 | 0.06 | 0.06 | 1,362,216 | |
10/14/2024 | 0.06 | 0.07 | 0.06 | 0.07 | 2,388,014 | |
10/11/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 262,932 | |
10/10/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 314,564 | |
10/09/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 313,512 | |
10/08/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 2,587,724 | |
10/07/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 297,979 | |
10/04/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 820,743 | |
10/03/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 833,425 | |
10/02/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 1,375,806 | |
10/01/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 843,396 | |
09/30/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 448,756 | |
09/27/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 428,743 | |
09/26/2024 | 0.06 | 0.06 | 0.05 | 0.06 | 2,686,033 | |
09/25/2024 | 0.06 | 0.06 | 0.05 | 0.06 | 1,044,202 | |
09/24/2024 | 0.06 | 0.07 | 0.05 | 0.06 | 5,027,981 | |
09/23/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 3,672,687 | |
09/20/2024 | 0.05 | 0.06 | 0.05 | 0.05 | 3,783,470 | |
09/19/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 996,185 | |
09/18/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 1,685,278 | |
09/17/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 455,114 | |
09/16/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 450,385 | |
09/13/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 1,855,943 | |
09/12/2024 | 0.04 | 0.05 | 0.04 | 0.05 | 4,892,824 | |
09/11/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 7,306,742 | |
09/10/2024 | 0.05 | 0.05 | 0.04 | 0.04 | 6,265,281 | |
09/09/2024 | 0.05 | 0.05 | 0.04 | 0.05 | 258,968 | |
09/06/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 1,564,009 | |
09/05/2024 | 0.05 | 0.05 | 0.04 | 0.05 | 5,021,068 | |
09/04/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 4,044,228 |
About Impedimed Stock history
Impedimed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Impedimed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Impedimed will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Impedimed stock prices may prove useful in developing a viable investing in Impedimed
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2 B | 2.1 B | |
Net Loss | -18.5 M | -19.4 M |
Impedimed Quarterly Net Working Capital |
|
Impedimed Stock Technical Analysis
Impedimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
All Next | Launch Module |
Impedimed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Impedimed's price direction in advance. Along with the technical and fundamental analysis of Impedimed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Impedimed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0154 | |||
Jensen Alpha | (0.06) | |||
Total Risk Alpha | (0.69) | |||
Sortino Ratio | (0.02) | |||
Treynor Ratio | 0.0436 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Impedimed Stock Analysis
When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.